In Vivo Preclinical Assessment of The VEGF Targeting Potential of The Newly Synthesized [52Mn]Mn-DOTAGA- Bevacizumab Using Experimental Cervix Carcinoma Mouse Model

A tétel rövid nézete
dc.contributor.authorCsikos Csaba
dc.contributor.departmentÁltalános Orvostudományi Karhu
dc.date.accessioned2023-06-22T20:11:49Z
dc.date.available2023-06-22T20:11:49Z
dc.date.issued2023-06
dc.identifier.urihttps://hdl.handle.net/2437/356083
dc.titleIn Vivo Preclinical Assessment of The VEGF Targeting Potential of The Newly Synthesized [52Mn]Mn-DOTAGA- Bevacizumab Using Experimental Cervix Carcinoma Mouse Model
Fájlok
Gyűjtemények
DETEP ÁOK